[
    [
        {
            "time": "",
            "orginal_text": "大分子生物药的机会",
            "features": {
                "keywords": [
                    "大分子",
                    "生物药",
                    "机会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "大分子生物药的机会",
            "scores": {
                "News_content": "大分子生物药的机会",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "科创板关注的五大行业独角兽企业都有谁",
            "features": {
                "keywords": [
                    "科创板",
                    "独角兽",
                    "行业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "科创板关注的五大行业独角兽企业都有谁",
            "scores": {
                "News_content": "科创板关注的五大行业独角兽企业都有谁",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "复星获欧盟批准，或收购德国服装零售商Tom Tailor",
            "features": {
                "keywords": [
                    "复星",
                    "欧盟",
                    "收购",
                    "德国",
                    "Tom Tailor"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "零售",
                    "国际并购"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星获欧盟批准，或收购德国服装零售商Tom Tailor",
            "scores": {
                "News_content": "复星获欧盟批准，或收购德国服装零售商Tom Tailor",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药：关于召开2019年第一次临时股东大会的通知",
            "features": {
                "keywords": [
                    "复星医药",
                    "股东大会",
                    "通知"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星医药：关于召开2019年第一次临时股东大会的通知",
            "scores": {
                "News_content": "复星医药：关于召开2019年第一次临时股东大会的通知",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "研发投入近2亿元 复宏汉霖阿达木单抗获上市申请受理",
            "features": {
                "keywords": [
                    "研发投入",
                    "复宏汉霖",
                    "阿达木单抗",
                    "上市申请"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "研发投入近2亿元 复宏汉霖阿达木单抗获上市申请受理",
            "scores": {
                "News_content": "研发投入近2亿元 复宏汉霖阿达木单抗获上市申请受理",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药周报2019第5期: 集采得到各方落实部署, 低估值得到有望迎来反转",
            "features": {
                "keywords": [
                    "医药",
                    "集采",
                    "落实部署",
                    "低估",
                    "反转"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药周报2019第5期: 集采得到各方落实部署, 低估值得到有望迎来反转",
            "scores": {
                "News_content": "医药周报2019第5期: 集采得到各方落实部署, 低估值得到有望迎来反转",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]